Glabridin from Licorice Root Extract: Tyrosinase Inhibition, Anti-Inflammatory Mechanisms, and 2026 Formulation Science
Among the most clini […]
Retinol for Hyperpigmentation: Why Vitamin A Remains the First-Line Melasma Adjunct in 2026
Clinical evidence and 2026 industry analysis: why retinol and retinoids remain first-line melasma adjuncts, and how gentle, encapsulated, combination regimens are reshaping brightening science.
未分类
Sepiwhite MSH (Undecylenoyl Phenylalanine): MC1R Antagonist, Formulation Guide, and Clinical Evidence
Sepiwhite MSH (Undecylenoyl Phenylalanine) is the only commercially viable MC1R antagonist for topical skincare. This guide covers its mechanism, clinical evidence, and practical 2026 formulation science.